| 03-11-2025 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            25,120 | 
            N/A | 
            0.75 | 
            0.89 | 
            BioNTech GAAP EPS of -€0.12, revenue of €1.52B  [11/3/2025 6:47 AM] | 
            104.04 | 
            0.13  (0.13%) | 
            105.48 | 
            1.57  (1.51%) | 
            81.20 - 129.27 | 
            742,403 | 
            570,000 | 
            46,195 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 04-08-2025 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            25,800 | 
            -1.82 | 
            -1.31 | 
            -3.62 | 
            BioNTech GAAP EPS of -€1.60, revenue of €260.8M  [8/4/2025 6:47 AM] | 
            110.11 | 
            2.77  (2.58%) | 
            112.43 | 
            5.09  (4.74%) | 
            76.53 - 131.49 | 
            737,595 | 
            680,000 | 
            15,989 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 05-05-2025 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            24,580 | 
            -1.82 | 
            -2.77 | 
            -1.42 | 
            BioNTech GAAP EPS of -€1.73, revenue of €182.8M; reaffirms FY25 outlook  [5/5/2025 6:48 AM] | 
            101.31 | 
            -3.63  (-3.46%) | 
            104.50 | 
            -0.44  (-0.42%) | 
            76.53 - 131.49 | 
            667,575 | 
            1,890,000 | 
            5,432 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 10-03-2025 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            26,350 | 
            1.15 | 
            0.57 | 
            2.05 | 
            BioNTech GAAP EPS of €1.08, revenue of €1.19B  [3/10/2025 6:58 AM] | 
            105.33 | 
            -3.45  (-3.17%) | 
            105.13 | 
            -3.65  (-3.35%) | 
            76.54 - 131.49 | 
            1,037,280 | 
            900,000 | 
            34,548 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 04-11-2024 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            26,890 | 
            0.89 | 
            -1.26 | 
            0.73 | 
            BioNTech reports Q3 results, reconfirms FY guidance  [11/4/2024 6:47 AM] | 
            109.05 | 
            -2.44  (-2.18%) | 
            113.00 | 
            1.52  (1.36%) | 
            76.53 - 131.49 | 
            615,306 | 
            680,000 | 
            18,258 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 05-08-2024 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            19,180 | 
            -3.62 | 
            -2.16 | 
            -0.86 | 
            BioNTech GAAP EPS of -€3.36, revenue of €128.7M  [8/5/2024 6:02 AM] | 
            78.32 | 
            -3.69  (-4.50%) | 
            76.95 | 
            -5.06  (-6.17%) | 
            76.53 - 125.83 | 
            1,488,854 | 
            580,000 | 
            66,803 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 06-05-2024 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            21,930 | 
            -1.42 | 
            -0.61 | 
            2.20 | 
            BioNTech GAAP EPS of -€1.31, revenue of €187.6M  [5/6/2024 7:03 AM] | 
            93.19 | 
            0.47  (0.51%) | 
            90.45 | 
            -2.27  (-2.45%) | 
            85.21 - 125.83 | 
            882,787 | 
            440,000 | 
            83,580 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 20-03-2024 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            22,410 | 
            2.05 | 
            2.64 | 
            9.46 | 
            BioNTech reports Q4 results  [3/20/2024 6:22 AM] | 
            90.01 | 
            -4.11  (-4.37%) | 
            88.72 | 
            -5.40  (-5.74%) | 
            85.21 - 136.91 | 
            2,588,797 | 
            570,000 | 
            194,540 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 06-11-2023 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            22,290 | 
            0.73 | 
            -0.58 | 
            7.04 | 
            BioNTech GAAP EPS of €0.67, revenue of €895.3M; updates FY23 guidance  [11/6/2023 6:47 AM] | 
            99.83 | 
            4.05  (4.23%) | 
            101.48 | 
            5.70  (5.95%) | 
            88.00 - 188.99 | 
            1,218,227 | 
            820,000 | 
            82,182 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 07-08-2023 | 
            PM | 
             | 
            BNTX | 
            BioNTech SE | 
            25,700 | 
            -0.86 | 
            -0.75 | 
            7.31 | 
            BioNTech GAAP EPS of -€0.79, revenue of €167.7M; reaffirms FY23 COVID-19 vaccine revenue guidance  [8/7/2023 6:04 AM] | 
            98.49 | 
            -7.99  (-7.50%) | 
            101.31 | 
            -5.17  (-4.86%) | 
            95.50 - 188.99 | 
            2,996,910 | 
            630,000 | 
            114,565 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 08-05-2023 | 
            PM | 
            6:00 AM ET  (May 8) | 
            BNTX | 
            BioNTech SE | 
            25,940 | 
            2.20 | 
            0.36 | 
            15.98 | 
            BioNTech beats Q1 top and bottom line estimates; reaffirms FY23 outlook  [5/8/2023 6:47 AM] | 
            107.94 | 
            -0.49  (-0.45%) | 
            113.01 | 
            4.58  (4.22%) | 
            106.64 - 188.99 | 
            1,098,181 | 
            700,000 | 
            42,003 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 27-03-2023 | 
            PM | 
            6:00 AM ET  (Mar 27) | 
            BNTX | 
            BioNTech SE | 
            32,670 | 
            9.46 | 
            8.68 | 
            13.93 | 
            BioNTech GAAP EPS of €9.26 beats by €1.51, revenue of €4.28B beats by €420M  [3/27/2023 6:54 AM] | 
            123.90 | 
            -4.30  (-3.35%) | 
            122.43 | 
            -5.77  (-4.50%) | 
            117.08 - 188.99 | 
            1,563,736 | 
            580,000 | 
            89,599 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 07-11-2022 | 
            PM | 
            6:00 AM ET  (Nov 7) | 
            BNTX | 
            BioNTech SE | 
            35,250 | 
            7.04 | 
            3.66 | 
            14.56 | 
            BioNTech GAAP EPS of €6.98, revenue of €3.46B  [11/7/2022 6:03 AM] | 
            160.68 | 
            6.37  (4.13%) | 
            152.19 | 
            -2.12  (-1.37%) | 
            117.08 - 369.68 | 
            1,738,609 | 
            890,000 | 
            94,398 | 
             | 
            
            
                
                
                    
                        
                            
                                        - 
                                            BioNTech GAAP EPS of €6.98, revenue of €3.46B [11/7/2022 6:03 AM]
                                        
 
                                        - 
                                            BioNTech dips as Q3 sales fall, raises lower end of revenue outlook as COVID boosters ship [11/7/2022 7:03 AM]
                                        
 
                                        - 
                                            Did Vaccine Stocks Just Get Their Last Boost? [Nov-04-22 06:17PM]
                                        
 
                                        - 
                                            Top Biotech Stocks for Q4 2022 [Nov-04-22 05:46PM]
                                        
 
                                        - 
                                            This Key Piece Of News Could Spark BioNTech, Moderna  And Stoke Demand For Covid Boosters [Nov-04-22 04:20PM]
                                        
 
                                        - 
                                            UPDATE 1-Pfizer/BioNTech Omicron shot shows strong response after a month [Nov-04-22 12:10PM]
                                        
 
                                        - 
                                            Pfizer-BioNTech bivalent booster shows higher immune response, but new COVID cases climb back above 40,000 a day [Nov-04-22 11:21AM]
                                        
 
                                        - 
                                            China Agrees to Approve BioNTech's Covid-19 Vaccine for Foreigners, German Chancellor Says [Nov-04-22 11:11AM]
                                        
 
                                        - 
                                            BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market [Nov-04-22 10:41AM]
                                        
 
                                        - 
                                            UPDATE 2-German expats in China will have access to BioNTech vaccine, says Scholz [Nov-04-22 09:51AM]
                                        
 
                                        - 
                                            UPDATE 1-Germany's Scholz secures deal for expats in China to use BioNTech vaccine [Nov-04-22 09:51AM]
                                        
 
                                        - 
                                            Pfizer/BioNTech Updated Omicron Adapted COVID-19 Vaccine Shows 4-Fold Higher Neutralizing Activity [Nov-04-22 09:43AM]
                                        
 
                                        - 
                                            Pfizer, BioNTech stocks rally after announcing positive trial data on BA.4/BA.5 bivalent booster shot [Nov-04-22 07:03AM]
                                        
 
                                        - 
                                            Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine [Nov-04-22 06:48AM]
                                        
 
                                        - 
                                            Pfizer and BioNTech Announce Updated Clinical Data for Omicron BA.4/BA.5-Adapted Bivalent Booster Demonstrating Substantially Higher Immune Response in Adults Compared to the Original COVID-19 Vaccine [Nov-04-22 06:47AM]
                                        
 
                                        - 
                                            Pfizer/BioNTech Omicron booster shows strong response after a month [Nov-04-22 06:46AM]
                                        
 
                                        - 
                                            Coronavirus tally: New daily cases rise above 40,000 in U.S., China reportedly looks into easing COVID restrictions [Nov-04-22 06:40AM]
                                        
 
                                        - 
                                            BioNTech stock surges toward 3-month high after report China agrees to approve its COVID vaccine for foreigners [Nov-04-22 06:23AM]
                                        
 
                                        - 
                                            Scholz secures agreement allowing expats in China to use BioNTech COVID-19 vaccine [Nov-04-22 06:22AM]
                                        
 
                                        - 
                                            BioNTech lifts lower end of vaccine sales target range [Nov-07-22 06:00AM]
                                        
 
                                        - 
                                            BioNTech Issues Bright Revenue Outlook. But The Stock Sinks After Profit Drop. [Nov-07-22 07:43AM]
                                        
 
                                        - 
                                            BioNTech Sees Some Vaccine Deliveries Shifting to Next Year [Nov-07-22 06:59AM]
                                        
 
                                        - 
                                            BioNTech profit and revenue fall sharply from year-ago period but top estimates [Nov-07-22 06:17AM]
                                        
 
                                        - 
                                            BioNTech Raises Covid Vaccine Sales Forecast as Boosters Ship [Nov-07-22 06:00AM]
                                        
 
                                        - 
                                            BioNTech Announces Third Quarter 2022 Financial Results and Corporate Update [Nov-07-22 06:00AM]
                                        
 
                             
                         
                        
                     
                 
                 | 
            
        
            | 08-08-2022 | 
            PM | 
            6:00 AM ET  (Aug 8) | 
            BNTX | 
            BioNTech SE | 
            38,920 | 
            7.31 | 
            8.12 | 
            12.98 | 
            BioNTech GAAP EPS of €6.45 misses by €0.63, revenue of €3.2B misses by €910M  [8/8/2022 6:04 AM] | 
            168.94 | 
            -14.16  (-7.74%) | 
            166.67 | 
            -16.44  (-8.98%) | 
            117.08 - 457.93 | 
            3,188,318 | 
            920,000 | 
            217,011 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 09-05-2022 | 
            PM | 
            6:00 AM ET  (May 9) | 
            BNTX | 
            BioNTech SE | 
            35,030 | 
            15.98 | 
            9.14 | 
            5.29 | 
            BioNTech GAAP EPS of €14.24, revenue of $6.4B beats by €1.91B  [5/9/2022 6:03 AM] | 
            139.72 | 
            3.56  (2.61%) | 
            137.80 | 
            1.63  (1.20%) | 
            121.32 - 464.00 | 
            2,283,797 | 
            1,120,000 | 
            103,892 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 30-03-2022 | 
            PM | 
            6:45 AM ET  (Mar 30) | 
            BNTX | 
            BioNTech SE | 
            40,340 | 
            13.93 | 
            8.02 | 
            1.87 | 
            BioNTech GAAP EPS of €12.18, revenue of €5.53B  [3/30/2022 6:10 AM] | 
            174.40 | 
            2.01  (1.17%) | 
            183.89 | 
            11.50  (6.67%) | 
            98.60 - 464.00 | 
            3,651,441 | 
            1,850,000 | 
            272,740 | 
             | 
            
            
                
                
                    
                        
                            
                                        - 
                                            Pfizer/BioNTech and Moderna win U.S. regulatory nod for second booster shot (updated) [3/29/2022 3:55 PM]
                                        
 
                                        - 
                                            BioNTech GAAP EPS of €12.18, revenue of €5.53B [3/30/2022 6:10 AM]
                                        
 
                                        - 
                                            BioNTech proposes €2.00 dividend, buyback of $1.5B [3/30/2022 6:38 AM]
                                        
 
                                        - 
                                            BioNTech Q4 profit soars on COVID vaccine sales; plans buyback, special dividend [3/30/2022 6:57 AM]
                                        
 
                                        - 
                                            Biden tells lawmakers to authorize billions in COVID spending [3/30/2022 4:21 PM]
                                        
 
                                        - 
                                            Why Moderna and BioNTech Were Winners Today [Mar-29-22 06:07PM]
                                        
 
                                        - 
                                            Coronavirus: FDA authorizes fourth COVID shots from Moderna and Pfizer [Mar-29-22 04:35PM]
                                        
 
                                        - 
                                            Moderna, BioNTech Pop After FDA OKs Another Covid Booster Round  But Not For Everyone [Mar-29-22 04:13PM]
                                        
 
                                        - 
                                            UPDATE 3-U.S. authorizes second COVID booster for Americans 50 and older [Mar-29-22 11:44AM]
                                        
 
                                        - 
                                            U.S. FDA authorizes second COVID booster dose for people aged 50 and older [Mar-29-22 11:06AM]
                                        
 
                                        - 
                                            COVID-19: FDA authorizes another Pfizer, Moderna booster shot for Americans 50 and up [Mar-29-22 11:05AM]
                                        
 
                                        - 
                                            FDA green lights second booster of Pfizer/BioNTech, Moderna COVID shot for older Americans [Mar-29-22 11:02AM]
                                        
 
                                        - 
                                            FDA authorizes second booster of Pfizer/BioNTech COVID shot [Mar-29-22 10:39AM]
                                        
 
                                        - 
                                            Pfizer and BioNTech Receive Expanded U.S. Emergency Use Authorization for an Additional COVID-19 Vaccine Booster in Individuals Aged 50 Years and Older [Mar-29-22 10:30AM]
                                        
 
                                        - 
                                            BioNTech to expand trial programme for more anti-Omicron vaccine options [Mar-30-22 06:00AM]
                                        
 
                                        - 
                                            BioNTech Announces Fourth Quarter and Full Year 2021 Financial Results and Corporate Update [Mar-30-22 06:00AM]
                                        
 
                                        - 
                                            BioNTechs Earnings Top Estimates. It Plans a Buyback and Special Dividend. [Mar-30-22 06:16AM]
                                        
 
                                        - 
                                            BioNTech reports soaring earnings, revenue on COVID vaccine, plans $1.5 billion in buybacks [Mar-30-22 06:43AM]
                                        
 
                                        - 
                                            UPDATE 1-BioNTech to expand trial programme for more anti-Omicron vaccine options [Mar-30-22 06:49AM]
                                        
 
                                        - 
                                            UPDATE 2-BioNTech to expand trial programme for more anti-Omicron vaccine options [Mar-30-22 06:49AM]
                                        
 
                                        - 
                                            Dow Jones Futures Today Dip Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 08:22AM]
                                        
 
                                        - 
                                            Coronavirus: FDA authorizes 4th COVID shots from Moderna and Pfizer [Mar-29-22 04:35PM]
                                        
 
                                        - 
                                            Dow Jones Futures Today Fall Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 08:34AM]
                                        
 
                                        - 
                                            BioNTech Stock Pops On Soaring Earnings, $1.5 Billion Share Buyback [Mar-30-22 09:00AM]
                                        
 
                                        - 
                                            Dow Jones Today Falls Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 09:35AM]
                                        
 
                                        - 
                                            BioNTech Soars on Q4 Beat, Special Dividend, Promise of Buyback [Mar-30-22 03:38AM]
                                        
 
                                        - 
                                            Dow Jones Today Firms Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 09:51AM]
                                        
 
                                        - 
                                            Dow Jones Firms Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 09:58AM]
                                        
 
                                        - 
                                            BioNTech: work on pan-variant COVID shots not yet ripe for clinical trials [Mar-30-22 09:19AM]
                                        
 
                                        - 
                                            Dow Jones Dips Amid Strong Market Rally; Apple, SolarEdge, Micron In Focus [Mar-30-22 10:24AM]
                                        
 
                                        - 
                                            Micron, Lululemon and BioNTech Rise Premarket; Five Below Falls [Mar-30-22 03:59AM]
                                        
 
                                        - 
                                            FDA Authorizes Pfizer, Moderna's Second COVID Booster Dose [Mar-30-22 09:18AM]
                                        
 
                                        - 
                                            Wall Street Opens Mostly Lower as Peace Hopes Damped; Dow Flat [Mar-30-22 05:52AM]
                                        
 
                                        - 
                                            Midday Stock Movers: Direct Digital, Lululemon Rally; Chewy Falls [Mar-30-22 07:42AM]
                                        
 
                                        - 
                                            CORRECTED-Pfizer/BioNTech COVID vaccine slashes pediatric hospitalization risk -U.S. study [Mar-30-22 05:00PM]
                                        
 
                                        - 
                                            Why These 10 Stocks Are on the Move on Wednesday [Mar-30-22 03:31PM]
                                        
 
                                        - 
                                            BioNTech SE (BNTX) Q4 2021 Earnings Call Transcript [Mar-30-22 08:00PM]
                                        
 
                             
                         
                        
                     
                 
                 | 
            
        
            | 09-11-2021 | 
            PM | 
            7:00 AM ET  (Nov 9) | 
            BNTX | 
            BioNTech SE | 
            66,440 | 
            14.56 | 
            11.79 | 
            -1.03 | 
            BioNTech EPS beats by $0.30; updates outlook for full year  [11/9/2021 6:51 AM] | 
            226.26 | 
            -16.34  (-6.74%) | 
            251.95 | 
            9.35  (3.85%) | 
            80.55 - 464.00 | 
            4,887,385 | 
            3,540,000 | 
            543,425 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 09-08-2021 | 
            PM | 
            7:00 AM ET  (Aug 9) | 
            BNTX | 
            BioNTech SE | 
            97,800 | 
            12.98 | 
            8.35 | 
            -0.42 | 
            BioNTech beats on revenue; issues full year guidance  [8/9/2021 7:09 AM] | 
            446.24 | 
            57.23  (14.71%) | 
            409.23 | 
            20.22  (5.20%) | 
            54.10 - 459.88 | 
            11,426,252 | 
            5,720,000 | 
            419,431 | 
             | 
            
            
                
                
                    
                        
                            
                                        - 
                                            Pfizer vaccine booster shot has similar side effects to 2nd dose: Israeli survey [8/9/2021 2:04 AM]
                                        
 
                                        - 
                                            Fauci favors speeding COVID-19 booster shots for vulnerable individuals [8/9/2021 6:55 AM]
                                        
 
                                        - 
                                            BioNTech beats on revenue; issues full year guidance [8/9/2021 7:09 AM]
                                        
 
                                        - 
                                            BioNTech raises projection for COVID-19 vaccine sales after delivering one billion doses [8/9/2021 8:51 AM]
                                        
 
                                        - 
                                            Dow Jones Futures: Market Rally Hits Highs As Apple, Tesla, Square Lead 6 Stocks Near Buy Points; What To Do Now [Aug-06-21 05:50PM]
                                        
 
                                        - 
                                            Novavax CEO explains delay in COVID-19 vaccine EUA filing [Aug-06-21 03:31PM]
                                        
 
                                        - 
                                            Why COVID Vaccines for Younger Kids Won't Win Authorization as Soon as Expected [Aug-06-21 06:08AM]
                                        
 
                                        - 
                                            Why COVID Vaccine Stocks Moderna, BioNTech, Novavax, and Dynavax Soared This Week [Aug-06-21 05:58AM]
                                        
 
                                        - 
                                            BioNTech Announces Second Quarter 2021 Financial Results and Corporate Update [Aug-09-21 07:00AM]
                                        
 
                                        - 
                                            BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far [Aug-09-21 07:00AM]
                                        
 
                                        - 
                                            UPDATE 1-BioNTech says has supplied more than 1 bln COVID-19 vaccine doses so far [Aug-09-21 08:01AM]
                                        
 
                                        - 
                                            BioNTech says has supplied more than 1 billion COVID-19 vaccine doses so far [Aug-09-21 08:09AM]
                                        
 
                                        - 
                                            Dow Jones Today, Futures, Global Markets Mixed As Oil Slides; Tesla Upgraded, BioNTech Rallies On Q2 Blowout [Aug-09-21 08:11AM]
                                        
 
                                        - 
                                            BioNTech Stock Pops On Massive Earnings Beat; Company Looks Beyond Covid [Aug-09-21 09:03AM]
                                        
 
                                        - 
                                            Dow Jones Today, Stocks Mixed As Oil Slides; Tesla Upgraded, BioNTech Rallies On Q2 Blowout [Aug-09-21 09:45AM]
                                        
 
                                        - 
                                            BioNTech Stock Climbs. Earnings Blew Past Expectations. [Aug-09-21 10:41AM]
                                        
 
                                        - 
                                            The Messenger RNA Vaccine Stocks Are the Best Investment Against COVID [Aug-09-21 06:45AM]
                                        
 
                                        - 
                                            BioNTech Stock Pops On Earnings Crush, Plans To Deliver 2.2 Billion Doses [Aug-09-21 09:03AM]
                                        
 
                                        - 
                                            BioNTech says vaccine repeats beat devising new one for now [Aug-09-21 08:09AM]
                                        
 
                                        - 
                                            UPDATE 2-BioNTech says vaccine repeats beat devising new one for now [Aug-09-21 08:01AM]
                                        
 
                                        - 
                                            BioNTech Soars As It Says Its Developing Updated Covid Shot For Delta [Aug-09-21 07:06AM]
                                        
 
                                        - 
                                            BioNTech Stock Jumps as COVID Vaccine Lifts Profit Past Estimates [Aug-09-21 08:09AM]
                                        
 
                                        - 
                                            Dow Jones Slips From Record High, Nasdaq Rises As Covid-19 Stocks Soar [Aug-09-21 12:31PM]
                                        
 
                                        - 
                                            Dow Jones Slips But Nasdaq Advances As These Covid Stocks Hit New Highs [Aug-09-21 01:43PM]
                                        
 
                                        - 
                                            COVID-19: In schools we should start at least implementing a testing requirement, doctor says [Aug-09-21 02:16PM]
                                        
 
                                        - 
                                            Vaccine stocks rally, DraftKings to buy Golden Nugget, Bitcoins weekend moves [Aug-09-21 02:47PM]
                                        
 
                                        - 
                                            Pfizer Expects $33.5 Billion In Full-Year Covid Vaccine Sales  Is PFE Stock A Buy? [Aug-09-21 03:22PM]
                                        
 
                                        - 
                                            Why Moderna, BioNTech, and Novavax Stock Soared Today [Aug-09-21 05:54PM]
                                        
 
                                        - 
                                            COVID SCIENCE-Moderna may be superior to Pfizer against Delta; breakthrough odds rise with time [Aug-09-21 04:36PM]
                                        
 
                                        - 
                                            BioNTech SE (BNTX) Q2 2021 Earnings Call Transcript [Aug-09-21 08:30PM]
                                        
 
                             
                         
                        
                     
                 
                 | 
            
        
            | 10-05-2021 | 
            PM | 
            6:30 AM ET  (May 10) | 
            BNTX | 
            BioNTech SE | 
            40,580 | 
            5.29 | 
            4.31 | 
            -0.26 | 
            BioNTech EPS beats by €1.33, beats on revenue  [5/10/2021 7:03 AM] | 
            202.49 | 
            18.78  (10.22%) | 
            200.20 | 
            16.49  (8.98%) | 
            45.08 - 213.15 | 
            6,619,873 | 
            5,360,000 | 
            421,507 | 
             | 
            
            
                
                
                    
                        
                            
                                        - 
                                            BioNTech EPS beats by €1.33, beats on revenue [5/10/2021 7:03 AM]
                                        
 
                                        - 
                                            BioNTech trades higher after raising 2021 guidance for COVID-19 vaccine sales [5/10/2021 7:44 AM]
                                        
 
                                        - 
                                            Pfizer/ BioNTech vaccine's protection against COVID-related deaths rises up to 97% after both doses: new study [5/10/2021 12:15 PM]
                                        
 
                                        - 
                                            World Health Organization names India COVID-19 variant as a global concern [5/10/2021 12:40 PM]
                                        
 
                                        - 
                                            FDA to hold AdCom meeting to discuss expanding COVID-19 vaccine use in children [5/10/2021 1:12 PM]
                                        
 
                                        - 
                                            Dubai Business Improves; BioNTechs Singapore Site: Virus Update [May-10-21 02:43AM]
                                        
 
                                        - 
                                            UPDATE 2-BioNTech to build mRNA manufacturing site in Singapore [May-10-21 02:22AM]
                                        
 
                                        - 
                                            BioNTech to build mRNA manufacturing site in Singapore [May-10-21 01:56AM]
                                        
 
                                        - 
                                            BioNTech to build mRNA manufacturing site in Singapore [May-10-21 01:48AM]
                                        
 
                                        - 
                                            BioNTech to Establish Regional Headquarters for South East Asia and First mRNA Manufacturing Facility in Singapore [May-10-21 01:31AM]
                                        
 
                                        - 
                                            BioNTech Chooses Singapore; Delhi Extends Lockdown: Virus Update [May-10-21 05:29AM]
                                        
 
                                        - 
                                            UPDATE 3-BioNTech to build mRNA vaccine manufacturing site in Singapore [May-10-21 02:22AM]
                                        
 
                                        - 
                                            BioNTech to build mRNA vaccine manufacturing site in Singapore [May-10-21 01:56AM]
                                        
 
                                        - 
                                            BioNTech SE - ADR to Host Earnings Call [May-10-21 06:15AM]
                                        
 
                                        - 
                                            BioNTech Announces First Quarter 2021 Financial Results and Corporate Update [May-10-21 07:00AM]
                                        
 
                                        - 
                                            BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year [May-10-21 07:16AM]
                                        
 
                                        - 
                                            UPDATE 4-BioNTech to build mRNA vaccine manufacturing site in Singapore [May-10-21 02:22AM]
                                        
 
                                        - 
                                            BioNTech Earnings Easily Beat, Covid Vaccine Maker Announces Asia Expansion; Stock Jumps [May-10-21 07:19AM]
                                        
 
                                        - 
                                            BioNTech shares soar 8% as COVID-19 vaccines drive revenue surge [May-10-21 07:45AM]
                                        
 
                                        - 
                                            Premarket Movers Monday - BioNTech, FireEye, Freeport-McMoRan, AMC [May-10-21 04:05AM]
                                        
 
                                        - 
                                            Dow Jones Today Gains, Nasdaq Futures Lag As Commodities Rally; Freeport Jumps, BioNTech Spikes On Asia Deal [May-10-21 08:13AM]
                                        
 
                                        - 
                                            BioNTech Sees Sales Boost; U.K. Lowers Alert Level: Virus Update [May-10-21 08:45AM]
                                        
 
                                        - 
                                            UPDATE 1-BioNTech committed to deliver 1.8 bln doses of COVID-19 vaccine this year [May-10-21 08:49AM]
                                        
 
                                        - 
                                            BioNTech shares soar 8% in premarket as COVID-19 vaccines help revenues smash estimates [May-10-21 09:00AM]
                                        
 
                                        - 
                                            BioNTech Delivers Blowout Q1 Results [May-10-21 09:25AM]
                                        
 
                                        - 
                                            BioNTech To Set Up Manufacturing Plant In Singapore [May-10-21 09:21AM]
                                        
 
                                        - 
                                            Dow Jones Today Rides Commodities Rally To New High, Nasdaq Lags; Freeport Jumps, BioNTech Spikes On Asia Deal [May-10-21 09:40AM]
                                        
 
                                        - 
                                            BioNTech Stock Jumps As It Plans New mRNA Manufacturing Facility In Singapore By 2023 [May-10-21 06:45AM]
                                        
 
                                        - 
                                            U.S. Cases Hit 8-Month Low; U.K. Eases Alert Level: Virus Update [May-10-21 10:25AM]
                                        
 
                                        - 
                                            When Will Adolescents Be Eligible for a Coronavirus Vaccine? [May-10-21 10:21AM]
                                        
 
                                        - 
                                            Dow Jones Rallies, Tech Stocks Dive As Covid Vaccine Maker Surges On Earnings; Apple, Tesla Sell Off [May-10-21 10:12AM]
                                        
 
                                        - 
                                            What BioNTechs Earnings Mean for the Drug Makers [May-10-21 10:12AM]
                                        
 
                                        - 
                                            Dow Jones Rallies 300 Points To Extend Win Streak; Nasdaq Drops As Tech Stocks Weigh [May-10-21 12:23PM]
                                        
 
                                        - 
                                            UPDATE 1-One AZ COVID-19 vaccine dose gives 80% lower death risk - English data [May-10-21 11:07AM]
                                        
 
                                        - 
                                            Indias COVID crisis deepens, as BioNTech says theres no evidence its vaccine needs adapting to cope with new variants [May-10-21 10:51AM]
                                        
 
                                        - 
                                            BioNTech shares soar 7% as COVID-19 vaccines help revenues smash estimates [May-10-21 08:59AM]
                                        
 
                                        - 
                                            BioNTech Stock Pops On Quadruple-Digit Sales Growth Amid Asia Expansion [May-10-21 11:01AM]
                                        
 
                                        - 
                                            COVID-19 is not at the point yet where we can have mass gatherings: Doctor [May-10-21 01:53PM]
                                        
 
                                        - 
                                            How This FDA Move Could Push Pfizer Stock Deeper Into A Winning Spree [May-10-21 06:04PM]
                                        
 
                                        - 
                                            FDA Clears Pfizer Shot for Teens; U.S. Cases Slow: Virus Update [May-10-21 05:27PM]
                                        
 
                                        - 
                                            FDA authorizes emergency use of Pfizer, BioNTech COVID vaccine to kids 12-15 [May-10-21 05:24PM]
                                        
 
                                        - 
                                            U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15 [May-10-21 05:23PM]
                                        
 
                                        - 
                                            U.S. authorizes Pfizer/BioNTech COVID vaccine for children 12 to 15 [May-10-21 05:14PM]
                                        
 
                                        - 
                                            BioNTechs Covid-19 Vaccine Success Sparks Investments in German Biotech [May-10-21 11:58AM]
                                        
 
                                        - 
                                            US drugs regulator authorises BioNTech/Pfizer Covid vaccine for under-16s [May-10-21 08:00PM]
                                        
 
                                        - 
                                            UPDATE 2-U.S. children ages 12 to 15 could begin COVID-19 vaccinations Thursday [May-10-21 05:23PM]
                                        
 
                             
                         
                        
                     
                 
                 | 
            
        
            | 30-03-2021 | 
            PM | 
            7:15 AM ET  (Mar 30) | 
            BNTX | 
            BioNTech SE | 
            23,060 | 
            1.87 | 
            -0.56 | 
            -0.29 | 
            BioNTech EPS beats by €1.67, beats on revenue  [3/30/2021 6:37 AM] | 
            104.84 | 
            8.93  (9.31%) | 
            99.60 | 
            3.69  (3.85%) | 
            37.00 - 131.00 | 
            3,204,686 | 
            1,150,000 | 
            121,263 | 
             | 
            
            
                
                
                    
                        
                            
                                        - 
                                            BioNTech Q4 2020 Earnings Preview [3/29/2021 2:27 PM]
                                        
 
                                        - 
                                            Pfizer/ BioNTech and Moderna vaccines are 80% effective in preventing COVID-19 infections after single dose [3/29/2021 11:45 AM]
                                        
 
                                        - 
                                            BioNTech COVID-19 vaccines delivered to Hong Kong are safe, an initial investigation finds [3/29/2021 11:12 AM]
                                        
 
                                        - 
                                            BioNTech EPS beats by €1.67, beats on revenue [3/30/2021 6:37 AM]
                                        
 
                                        - 
                                            BioNTech rises after earnings beat; raises 2021 manufacturing capacity [3/30/2021 7:25 AM]
                                        
 
                                        - 
                                            CDC Head Expresses Sense Of 'Impending Doom' Despite New Vaccine Study [Mar-29-21 04:20PM]
                                        
 
                                        - 
                                            Space ETF, BioNTech, Chewy Profits: 3 Things to Watch [Mar-29-21 11:47AM]
                                        
 
                                        - 
                                            Pfizer, Moderna Vaccines Prevent COVID-19; CDC Warns of 'Doom' [Mar-29-21 09:22AM]
                                        
 
                                        - 
                                            Pound pushes higher on vaccine optimism and reopening of UK economy [Mar-29-21 09:07AM]
                                        
 
                                        - 
                                            Taiwan says no progress in BioNTech vaccine talks [Mar-29-21 02:35AM]
                                        
 
                                        - 
                                            AstraZeneca woes continue as Canada suspends its jab for over-55s [Mar-30-21 05:56AM]
                                        
 
                                        - 
                                            BioNTech SE - ADR to Host Earnings Call [Mar-30-21 06:15AM]
                                        
 
                                        - 
                                            BioNTech Announces Full Year 2020 Financial Results and Corporate Update [Mar-30-21 06:30AM]
                                        
 
                                        - 
                                            BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses [Mar-30-21 06:37AM]
                                        
 
                                        - 
                                            UPDATE 1-BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses [Mar-30-21 07:15AM]
                                        
 
                                        - 
                                            BioNTech Expects $11.5 Billion in Covid-19 Vaccine Revenue [Mar-30-21 07:58AM]
                                        
 
                                        - 
                                            New COVID strain detected in Israel; Pfizer vaccine purchase bid delayed [Mar-30-21 08:47AM]
                                        
 
                                        - 
                                            BioNTech increases Covid vaccine production target to 2.5bn doses [Mar-29-21 08:00PM]
                                        
 
                                        - 
                                            UPDATE 2-BioNTech-Pfizer raise 2021 vaccine output goal to 2.5 bln doses [Mar-30-21 07:15AM]
                                        
 
                                        - 
                                            AstraZeneca woes continue as Berlin, Canada suspend jab [Mar-30-21 05:56AM]
                                        
 
                                        - 
                                            BioNTech owners in talks to invest in German cancer labs group -sources [Mar-30-21 09:22AM]
                                        
 
                                        - 
                                            BioNTech's Q4 Results Wowed but Were Just the Tip of the Iceberg [Mar-30-21 10:00AM]
                                        
 
                                        - 
                                            BioNTech Stock Pops As Company Projects $11.5 Billion In Covid Vaccine Sales [Mar-30-21 09:50AM]
                                        
 
                                        - 
                                            BioNTech and Pfizer Boost 2021 Vaccine Target to 2.5B Doses [Mar-30-21 05:47AM]
                                        
 
                                        - 
                                            Biotech emerges as 'superhero' of global pandemic [Mar-30-21 10:40AM]
                                        
 
                                        - 
                                            Why the COVID superhero villain tug-of-war will be an eternal battle [Mar-30-21 10:44AM]
                                        
 
                                        - 
                                            Why BioNTech Stock Is Jumping Today [Mar-30-21 11:39AM]
                                        
 
                                        - 
                                            5 Top Stock Gainers for Tuesday: Yelp, BioNTech, McCormick [Mar-30-21 08:10AM]
                                        
 
                                        - 
                                            BioNTech Stock Is Trading Higher On First Annual Profit; Raises 2021 Production Target For COVID-19 Shots To 2.5B Doses [Mar-30-21 09:36AM]
                                        
 
                                        - 
                                            We can vaccinate our way out of this phase of the pandemic: Doctor [Mar-30-21 01:27PM]
                                        
 
                                        - 
                                            BioNTech Jumps After Raising Its Covid Vaccine Goal to 2.5 Billion Doses [Mar-30-21 09:03AM]
                                        
 
                                        - 
                                            5 Top Stock Gainers for Tuesday: Yelp, BioNTech, General Motors [Mar-30-21 12:39PM]
                                        
 
                             
                         
                        
                     
                 
                 | 
            
        
            | 10-11-2020 | 
            PM | 
            6:00 AM ET  (Nov 10) | 
            BNTX | 
            BioNTech SE | 
            21,910 | 
            -1.03 | 
            -0.46 | 
            -0.16 | 
            BioNTech EPS misses by €0.50, beats on revenue  [11/10/2020 7:19 AM] | 
            112.75 | 
            7.95  (7.59%) | 
            110.08 | 
            5.28  (5.04%) | 
            17.07 - 115.00 | 
            6,927,712 | 
            3,141,858 | 
            913,552 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 11-08-2020 | 
            PM | 
            8:05 AM ET  (Aug 11) | 
            BNTX | 
            BioNTech SE | 
            18,340 | 
            -0.42 | 
            -0.29 | 
            0.00 | 
            BioNTech EPS misses by $0.28, misses on revenue  [8/11/2020 6:09 AM] | 
            72.36 | 
            -1.60  (-2.16%) | 
            69.20 | 
            -4.75  (-6.42%) | 
            12.52 - 105.00 | 
            2,547,133 | 
            3,287,496 | 
            170,475 | 
             | 
            
            
                | 
                
                 | 
            
        
            | 12-05-2020 | 
            PM | 
            6:40 AM ET  (May 12) | 
            BNTX | 
            BioNTech SE | 
            11,170 | 
            -0.26 | 
            -0.30 | 
            0.00 | 
            BioNTech EPS beats by €0.01, beats on revenue  [5/12/2020 8:14 AM] | 
            49.33 | 
            -0.65  (-1.30%) | 
            49.31 | 
            -0.02  (-0.04%) | 
            12.52 - 105.00 | 
            1,822,879 | 
            1,286,757 | 
            4,965 | 
             | 
            
            
                | 
                
                 |